SCHEMBL23997642

SCHEMBL23997642

CNCC(CNC)CSP(=O)(OC(C)OC(=O)C(C)(C)C)OC(C)OC(=O)C(C)(C)C

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
CYP3A4 P08684 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25625848 0.89 BTN3A1 (0.34) ALDH1A1
SCHEMBL30360158 0.88
SCHEMBL23997454 0.76
SCHEMBL29026074 0.75
SCHEMBL23997623 0.73
SCHEMBL25626154 0.69
SCHEMBL23997509 0.69 IDO1 (0.33)
SCHEMBL23997621 0.68 ANPEP (0.31)
SCHEMBL24106670 0.68
SCHEMBL17323854 0.67 PRKCA (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174562-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS Tonix Pharmaceuticals, Inc. 2023-06-08 US disclosed
US-20230174562-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS Tonix Pharmaceuticals, Inc. 2023-06-08 US disclosed
US-20230138150-A1 RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS Tonix Pharmaceuticals, Inc. 2023-05-04 US disclosed
US-20230138150-A1 RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS Tonix Pharmaceuticals, Inc. 2023-05-04 US disclosed
EP-4146662-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS Tonix Pharmaceuticals, Inc. (US) 2023-03-15 EP disclosed
US-11566032-B2 Radio-protective and chemo-protective substituted thiols Tonix Pharmaceuticals, Inc. (US) 2023-01-31 US disclosed
US-20210388011-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS TONIX PHARMACEUTICALS HOLDING CORP. 2021-12-16 US disclosed
WO-2021226559-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS Tonix Pharmaceuticals, Inc. (US) 2021-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174562-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS MGMT, RCOR3, TSPO ALDH1A1 926/4885LMNA 39/4885CYP3A4 2796/4885
US-20210388011-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS MGMT, GSTP1, GSTA1 ALDH1A1 152/4885LMNA 4006/4885CYP3A4 1112/4885
US-11566032-B2 Radio-protective and chemo-protective substituted thiols MGMT, GSTP1, GSTA1 ALDH1A1 239/4885LMNA 4388/4885CYP3A4 940/4885
US-20230138150-A1 RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS MGMT, GSTA1, GSTP1 ALDH1A1 93/4885LMNA 4389/4885CYP3A4 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.